As the global pharmaceutical industry navigates the dynamic landscape of clinical research, China has firmly established its dominance in trial…
Read More
Aligos Therapeutics Licenses Pevifoscorvir Sodium to Xiamen Amoytop Biotech for Greater China, Bolstering HBV Treatment Landscape
Aligos Therapeutics has entered into an exclusive licensing agreement with Xiamen Amoytop Biotech, granting the Chinese biopharmaceutical company the rights…
Read More
RoosterBio and MineBio Forge Exclusive Partnership to Accelerate MSC and Exosome Therapies in China
RoosterBio, a prominent innovator in the field of mesenchymal stem cell (MSC) and exosome bioprocessing, has announced an exclusive distributor…
Read More
